Recognizing β-glucan Impurities in Biopharmaceuticals

In this webinar, we will discuss the known sources of β-glucan and highlight downstream processes that can reduce β-glucan. We will also address how to reduce false-positive results.

Register Free: https://www.pharmtech.com/pt_w/recognizing

Event Overview:

β-glucan process-related impurities introduced into pharmaceutical products during manufacturing can cause false-positive results on endotoxin tests. In this webinar, we will discuss the known sources of β-glucan and which downstream processes can reduce β-glucan. We will also address how to reduce false-positive results.

Speaker:

Soon-bin Kwon
Senior scientist (MSAT DSP)
Samsung Biologics

Soon-bin Kwon is a senior scientist in MSAT DSP at Samsung Biologics since 2019. He obtained his Ph.D. in Biotechnology from Yonsei University in Korea. He has extensive experience in downstream process tech transform from 10L lab scale to 15,000L GMP scale.

Register Free: https://www.pharmtech.com/pt_w/recognizing